|
01 Jun 2007 |
MIV Therapeutics Announces Start of Clinical Trial Marking First Ever Human Implantation of A Hydroxyapatite Coated Stent
|
|
01 Jun 2007 |
Peregrine Pharmaceuticals Enters Into Development Collaboration with Dios Therapeutics
|
|
31 May 2007 |
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
|
|
31 May 2007 |
Novacea and Schering-Plough Enter into Worldwide Development and Commercialization Agreement for Asentar, a Novel Treatment for Prostate Cancer
|
|
31 May 2007 |
BioWa and Takeda announce licensing of BioWa's POTELLIGENT(R) technology for use in antibody research and development
|
|
31 May 2007 |
Mylan Announces Final FDA Approval for Fluoxetine Capsules USP, 40 mg
|
|
31 May 2007 |
Mersana Therapeutics, Inc. Initiates Phase I Trial of Anti-Cancer Agent, XMT-1001, in Solid Tumors
|
|
31 May 2007 |
CeNeRx BioPharma, Inc. Announces Agreement With PharmaNess Neuroscience to Develop Novel Cannabinoid Compounds
|
|
30 May 2007 |
Positive Final Data from HyCAMPTM Phase II Trial in Metastatic Colorectal Cancer
|
|
30 May 2007 |
Genzyme Corporation to Acquire Bioenvision, Inc.
|
|
30 May 2007 |
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec(R)
|
|
30 May 2007 |
Angiotech initiates european trial examining the Vascular Wrapâ„¢ paclitaxel-eluting mesh for dialysis patients with end-stage renal disease
|
|
29 May 2007 |
Ranbaxy expands its presence in the us dermatology market
|
|
29 May 2007 |
Miraculins Announces Positive Final Results in Pivotal Prostate Cancer Biomarker Study
|
|
29 May 2007 |
FUJIFILM, Cangen Biotechnologies Joint Development Agreement on Anti-cancer Drug Delivery System
|
|
26 May 2007 |
Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
|
|
26 May 2007 |
Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
|
|
25 May 2007 |
Micromet and Nycomed Enter Into Exclusive Worldwide Collaboration to Develop and Commercialize Anti-GM-CSF Antibodies for the Treatment of Inflammatory and Autoimmune Diseases
|
|
25 May 2007 |
Emisphere Announces Initiation of Phase III Clinical Program of Oral Calcitonin for the Treatment of Osteoarthritis
|
|
25 May 2007 |
Inovio Biomedical’s DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
|
|
24 May 2007 |
Abbott Initiates First Clinical Study of Everolimus Eluting Stent System for Patients with Peripheral Arterial Disease
|
|
24 May 2007 |
Organon and Philips team up to study drug effects at the molecular level
|
|
24 May 2007 |
ThromboGenics plans to absorb Belgian subsidiary Thromb-X
|
|
23 May 2007 |
Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine
|
|
23 May 2007 |
Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
|
